We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
-6.47%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$445M
AUM Growth
-$87.7M
Cap. Flow
-$104M
Cap. Flow %
-23.3%
Top 10 Hldgs %
44.55%
Holding
123
New
13
Increased
19
Reduced
43
Closed
33

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$12.7M
2
MRK icon
Merck
MRK
+$11.3M
3
VZ icon
Verizon
VZ
+$10.3M
4
SBUX icon
Starbucks
SBUX
+$7.1M
5
EEFT icon
Euronet Worldwide
EEFT
+$6.91M

Top Sells

Rank Stock Value
1
TEAM icon
Atlassian
TEAM
+$15M
2
FTNT icon
Fortinet
FTNT
+$11.9M
3
AMZN icon
Amazon
AMZN
+$8.98M
4
SIVB
SVB Financial Group
SIVB
+$8.35M
5
CNC icon
Centene
CNC
+$8.34M

Sector Composition

Rank Sector Weight
1 Healthcare 27.45%
2 Financials 26.95%
3 Technology 16.16%
4 Consumer Discretionary 9.02%
5 Consumer Staples 8.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MASI
51
DELISTED
Masimo
MASI
$2.07M 0.47%
19,300
-600
-3% -$66.9K
WBD icon
52
Warner Bros
WBD
$64.6B
$2.05M 0.46%
+83,000
New +$2.53M
ATO icon
53
Atmos Energy
ATO
$29.9B
$1.97M 0.44%
21,200
-200
-0.9% -$19.1K
ALXN
54
DELISTED
Alexion Pharmaceuticals
ALXN
$1.89M 0.42%
19,410
-586
-3% -$69.3K
SYY icon
55
Sysco
SYY
$39.7B
$1.8M 0.41%
28,800
-6,700
-19% -$452K
AVGO icon
56
Broadcom
AVGO
$1.82T
$1.61M 0.36%
63,500
-75,550
-54% -$1.78M
GILD icon
57
Gilead Sciences
GILD
$161B
$1.54M 0.35%
24,690
-685
-3% -$47.9K
NFLX icon
58
Netflix
NFLX
$292B
$1.44M 0.32%
53,800
-4,500
-8% -$135K
NKE icon
59
Nike
NKE
$61.9B
$1.27M 0.29%
17,200
– –
JNJ icon
60
Johnson & Johnson
JNJ
$634B
$1.17M 0.26%
9,050
– –
NBIX icon
61
Neurocrine Biosciences
NBIX
$17.7B
$1.16M 0.26%
16,300
-600
-4% -$57.5K
BFAM icon
62
Bright Horizons
BFAM
$3.99B
$1.14M 0.26%
10,200
-100
-1% -$11.5K
T icon
63
AT&T
T
$165B
$1.02M 0.23%
47,340
-397
-0.8% -$9.24K
RGA icon
64
Reinsurance Group of America
RGA
$15.7B
$967K 0.22%
+6,900
New +$978K
MAS icon
65
Masco
MAS
$16B
$921K 0.21%
31,500
-3,850
-11% -$120K
GIS icon
66
General Mills
GIS
$19.2B
$817K 0.18%
21,000
-800
-4% -$33.8K
HQY icon
67
HealthEquity
HQY
$7.91B
$790K 0.18%
13,250
-81,800
-86% -$6.59M
C icon
68
Citigroup
C
$222B
$738K 0.17%
14,182
-900
-6% -$57K
CGNX icon
69
Cognex
CGNX
$10.3B
$684K 0.15%
17,700
-200
-1% -$8.67K
MGA icon
70
Magna International
MGA
$17.9B
$679K 0.15%
14,950
– –
CMD
71
DELISTED
Cantel Medical Corporation
CMD
$677K 0.15%
9,100
-1,400
-13% -$116K
CTAS icon
72
Cintas
CTAS
$82.4B
$655K 0.15%
15,600
-145,200
-90% -$6.49M
CTSH icon
73
Cognizant
CTSH
$21.5B
$635K 0.14%
10,008
-5,900
-37% -$410K
SHW icon
74
Sherwin-Williams
SHW
$78.3B
$609K 0.14%
4,650
-2,700
-37% -$364K
IART icon
75
Integra LifeSciences
IART
$1.54B
$539K 0.12%
11,954
– –
1 2
3
4 5

Similar funds

ECA
Endeavour Capital Advisors Greenwich, Connecticut $441M AUM 21.38% 1-Year Est. Return
DWML
Decker Wealth Management LLC Nashville, Tennessee $441M AUM
BOA
Birnam Oak Advisors New York $441M AUM 37.12% 1-Year Est. Return
PLU
Performa Ltd (US) Charleston, South Carolina $442M AUM 13.84% 1-Year Est. Return
CPW
Cove Private Wealth Oyster Bay Cove, New York $440M AUM 27.56% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
EFMC
Empire Financial Management Company New York $442M AUM 24.42% 1-Year Est. Return

De Burlo Group's Q4 2018 Portfolio in Review

As of Q4 2018, De Burlo Group held 123 positions worth $445M, down 16% from $533M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

De Burlo Group withdrew a net $104M in Q4 2018, closing 33 positions and reducing 43 holdings. Its most notable exit was Atlassian, an estimated $15M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 29% a quarter earlier, followed by Financials and Technology.

Against the trend, De Burlo Group opened a new position in Merck worth $11.7M.

  • De Burlo Group's largest Q4 2018 buy was Merck: 160,239 shares worth $11.7M.
  • De Burlo Group added most to Procter & Gamble in Q4 2018, an estimated $12.7M increase.
  • De Burlo Group's biggest Q4 2018 reduction was Amazon, cutting an estimated $8.98M.
  • De Burlo Group fully exited Atlassian in Q4 2018, selling an estimated $15M.
  • De Burlo Group's ten largest holdings make up 45% of its $445M portfolio in Q4 2018.
  • De Burlo Group opened 13 new positions and closed 33 in Q4 2018.
  • De Burlo Group's portfolio value fell 16% quarter-over-quarter to $445M.

Based on De Burlo Group's 13F filing for Q4 2018, filed 7 Feb 2019.